{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:36:38Z","timestamp":1770464198651,"version":"3.49.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005883","name":"Hertz Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>COVID-19 is associated with subclinical myocardial injury. Exogenous ketone esters acutely improve left myocardial function in healthy participants and patients with heart failure, but the effects have not been investigated in participants previously hospitalized for COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a randomized placebo-controlled double-blind crossover study comparing a single oral ketone ester dose of 395 mg\/kg with placebo. Fasting participants were randomized to either placebo in the morning and oral ketone ester in the afternoon or vice versa. Echocardiography was performed immediately after intake of the corresponding treatment. Primary outcome was left ventricular ejection fraction (LVEF). Secondary outcomes were absolute global longitudinal strain (GLS), cardiac output and blood oxygen saturation. Linear mixed effects models were used to assess differences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 12 participants previously hospitalized for COVID-19 with a mean (\u00b1SD) age of 60 \u00b1 10 years. The mean time from hospitalization was 18 \u00b1 5 months. Oral ketone esters did not increase LVEF between placebo and oral ketone ester [mean difference: \u22120.7% (95% CI \u22124.0 to 2.6%), <jats:italic>p<\/jats:italic> = 0.66], but increased GLS [1.9% (95% CI: 0.1 to 3.6%), <jats:italic>p<\/jats:italic> = 0.04] and cardiac output [1.2 L\/min (95% CI: \u22120.1 to 2.4 L\/min), <jats:italic>p<\/jats:italic> = 0.07], although non-significant. The differences in GLS remained significant after adjustment for change in heart rate (<jats:italic>p<\/jats:italic> = 0.01). There was no difference in blood oxygen saturation. Oral ketone esters increased blood ketones over time (peak level 3.1 \u00b1 4.9 mmol\/L, <jats:italic>p<\/jats:italic> &amp;lt; 0.01). Ketone esters increased blood insulin, c-peptide, and creatinine, and decreased glucose and FFA (all <jats:italic>p<\/jats:italic> \u2264 0.01) but did not affect glucagon, pro-BNP, or troponin I levels (all <jats:italic>p<\/jats:italic> &amp;gt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients previously hospitalized with COVID-19, a single oral dose of ketone ester had no effect on LVEF, cardiac output or blood oxygen saturation, but increased GLS acutely.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/clinicaltrials.gov\/<\/jats:ext-link>, identifier NCT04377035.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2023.1131192","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T07:29:12Z","timestamp":1675927752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover study"],"prefix":"10.3389","volume":"10","author":[{"given":"Helena Zander","family":"Wodschow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip S\u00f8skov","family":"Davidovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats Christian H\u00f8jbjerg","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer Grundtvig","family":"Skaarup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Nygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Rungby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Jacqueline","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Christian","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.jacc.2020.08.069","article-title":"Characterization of myocardial injury in patients with COVID-19.","volume":"76","author":"Giustino","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/bmm-2020-0388","article-title":"Evaluation of the relation between cardiac biomarkers and thorax computed tomography findings in COVID-19 patients.","volume":"15","author":"Ileri","year":"2021","journal-title":"Biomark Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.pcad.2020.04.008","article-title":"The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis.","volume":"63","author":"Li","year":"2020","journal-title":"Prog Cardiovasc Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1002\/ehf2.13044","article-title":"Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study.","volume":"7","author":"Lassen","year":"2020","journal-title":"ESC Heart Fail."},{"key":"B5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.amjcard.2021.10.046","article-title":"Global longitudinal strain to predict respiratory failure and death in patients admitted for COVID-19-related disease.","volume":"165","author":"Bevilacqua","year":"2022","journal-title":"Am J Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s15010-020-01572-8","article-title":"Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury.","volume":"49","author":"Bieber","year":"2021","journal-title":"Infection."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e366","article-title":"Cardiac manifestations of coronavirus disease 2019 (COVID-19): a multicenter cohort study.","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00519-3","article-title":"Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis.","volume":"9","author":"Wibowo","year":"2021","journal-title":"J Intensive Care."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.632434","article-title":"Biventricular longitudinal strain predict mortality in COVID-19 patients.","volume":"7","author":"Xie","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100018","article-title":"Understanding the role of left and right ventricular strain assessment in patients hospitalized with COVID-19.","volume":"6","author":"Park","year":"2021","journal-title":"Am Heart J Plus."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/ejhf.2326","article-title":"Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection.","volume":"23","author":"Lambadiari","year":"2021","journal-title":"Eur J Heart Fail."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/biology10111201","article-title":"Subclinical myocardial dysfunction in patients recovered from COVID-19 disease: correlation with exercise capacity.","volume":"10","author":"Shimoni","year":"2021","journal-title":"Biology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19.","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2213-260000160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2013 Final report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(21)04383-7","article-title":"Effect Of tocilizumab on cardiac injury and dysfunction in COVID-19.","author":"Zafar","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/PHM.0000000000001549","article-title":"Feasibility and efficacy of cardiopulmonary rehabilitation after COVID-19.","volume":"99","author":"Hermann","year":"2020","journal-title":"Am J Phys Med Rehabil."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients.","volume":"139","author":"Nielsen","year":"2019","journal-title":"Circulation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/ejhf.2347","article-title":"Recovery of cardiac function following COVID-19 \u2013 ECHOVID-19: a prospective longitudinal cohort study.","volume":"23","author":"Lassen","year":"2021","journal-title":"Eur J Heart Fail."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans.","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front Physiol."},{"key":"B24","year":"2021","journal-title":"R: A language and environment for statistical computing"},{"key":"B25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.echo.2021.10.017","article-title":"Acute echocardiographic effects of exogenous ketone administration in healthy participants.","volume":"35","author":"Selvaraj","year":"2022","journal-title":"J Am Soc Echocardiogr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart.","volume":"370","author":"Murashige","year":"2020","journal-title":"Science."},{"key":"B27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0735-109700214-8","article-title":"Blood ketone bodies in congestive heart failure.","volume":"28","author":"Lommi","year":"1996","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154452","article-title":"Myocardial ketone body utilization in patients with heart failure: the impact of oral ketone ester.","volume":"115","author":"Monzo","year":"2021","journal-title":"Metabolism."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165739","article-title":"Cardiac ketone body metabolism.","volume":"1866","author":"Abdul Kadir","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/01.CIR.0000139340.88769.D5","article-title":"Cardiac metabolism as a target for the treatment of heart failure.","volume":"110","author":"Taegtmeyer","year":"2004","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure.","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cjca.2017.03.009","article-title":"Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.","volume":"33","author":"De Jong","year":"2017","journal-title":"Can J Cardiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005066","article-title":"Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study.","volume":"6","author":"Gormsen","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","article-title":"Implications of altered ketone metabolism and therapeutic ketosis in heart failure.","volume":"141","author":"Selvaraj","year":"2020","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes.","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes."},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-673632590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure.","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis.","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01618-1","article-title":"Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial.","volume":"21","author":"Nesti","year":"2022","journal-title":"Cardiovasc Diabetol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1249\/MSS.0000000000001292","article-title":"A ketone ester drink increases postexercise muscle glycogen synthesis in humans.","volume":"49","author":"Holdsworth","year":"2017","journal-title":"Med Sci Sports Exerc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/jc.2014-2608","article-title":"Systemic, cerebral and skeletal muscle ketone body and energy metabolism during acute hyper-D-\u03b2-hydroxybutyratemia in post-absorptive healthy males.","volume":"100","author":"Mikkelsen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","article-title":"Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.","volume":"125","author":"Chokshi","year":"2012","journal-title":"Circulation."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa370","article-title":"Ketone body, 3-hydroxybutyrate: minor metabolite \u2013 Major medical manifestations.","volume":"105","author":"M\u00f8ller","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1648","article-title":"Long covid-mechanisms, risk factors, and management.","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1131192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T07:29:16Z","timestamp":1675927756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1131192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":44,"alternative-id":["10.3389\/fnut.2023.1131192"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1131192","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"article-number":"1131192"}}